ARKF vs. ESPR
ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK, while ESPR (Esperion Therapeutics, Inc.) is a stock. Over the past 5 years, ARKF returned -5.06%/yr vs -34.62%/yr for ESPR. At a 0.28 correlation, their price movements are largely independent.
Performance
ARKF vs. ESPR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKF achieves a -18.31% return, which is significantly lower than ESPR's -14.86% return.
ARKF
- 1D
- 0.00%
- 1M
- -5.76%
- YTD
- -18.31%
- 6M
- -21.31%
- 1Y
- -11.87%
- 3Y*
- 23.97%
- 5Y*
- -5.06%
- 10Y*
- —
ESPR
- 1D
- 0.00%
- 1M
- 0.96%
- YTD
- -14.86%
- 6M
- -18.18%
- 1Y
- 162.50%
- 3Y*
- 35.36%
- 5Y*
- -34.62%
- 10Y*
- -14.95%
ARKF vs. ESPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | -18.31% | 28.67% | 34.34% | 93.27% | -65.07% | -17.82% | 108.03% | 20.45% |
ESPR Esperion Therapeutics, Inc. | -14.86% | 68.18% | -26.42% | -52.01% | 24.60% | -80.77% | -56.40% | 28.68% |
Correlation
The correlation between ARKF and ESPR is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2019 | 0.29 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKF vs. ESPR — Risk / Return Rank
ARKF
ESPR
ARKF vs. ESPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Fintech Innovation ETF (ARKF) and Esperion Therapeutics, Inc. (ESPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKF | ESPR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.12 | ||
| Sortino ratioReturn per unit of downside risk | -3.14 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.36 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.31 | 3.07 | -3.38 |
| Martin ratioReturn relative to average drawdown | -0.57 | 7.68 | -8.25 |
Loading charts...
Drawdowns
ARKF vs. ESPR - Drawdown Comparison
The maximum ARKF drawdown since its inception was -78.63%, smaller than the maximum ESPR drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for ARKF and ESPR.
Loading charts...
Drawdown Indicators
| ARKF | ESPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.63% | -99.37% | +20.74% |
Max Drawdown (1Y)Largest decline over 1 year | -38.50% | -53.19% | +14.69% |
Max Drawdown (3Y)Largest decline over 3 years | -38.50% | -80.94% | +42.44% |
Max Drawdown (5Y)Largest decline over 5 years | -75.30% | -97.16% | +21.86% |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.10% | — |
Current DrawdownCurrent decline from peak | -38.77% | -97.27% | +58.50% |
Average DrawdownAverage peak-to-trough decline | -34.95% | -69.99% | +35.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.00% | 21.30% | -0.30% |
Volatility
ARKF vs. ESPR - Volatility Comparison
ARK Fintech Innovation ETF (ARKF) has a higher volatility of 10.36% compared to Esperion Therapeutics, Inc. (ESPR) at 1.06%. This indicates that ARKF's price experiences larger fluctuations and is considered to be riskier than ESPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKF | ESPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.36% | 1.06% | +9.30% |
Volatility (6M)Calculated over the trailing 6-month period | 25.14% | 61.44% | -36.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.69% | 92.66% | -58.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.87% | 91.79% | -48.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.77% | 84.61% | -44.84% |
Dividends
ARKF vs. ESPR - Dividend Comparison
ARKF's dividend yield for the trailing twelve months is around 0.11%, while ESPR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | 0.11% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% |
ESPR Esperion Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKF and ESPR have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKF has higher volatility (10.36%) compared to ESPR (1.06%). In terms of maximum drawdown, ARKF dropped -78.63% vs ESPR's -99.37%.
ESPR currently has the higher Sharpe Ratio (1.76 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKF and ESPR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer